Amgen quarterly profit tops Wall Street view, sales up 11%
The biotechnology company reported adjusted earnings per share of $4.90 for the quarter, sailing past the average analyst estimate of $4.30, as compiled by LSEG.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
Overall revenue rose 9% to $8.1 billion, which was in line with Wall Street estimates.
"Ongoing new product launches and successful Phase 3 trial results for several products make us feel confident in our long-term growth prospects," Amgen CEO Robert Bradway said in a statement.
The company is slated to present at a medical meeting next month full results from a mid-stage trial of its experimental weight-loss drug MariTide, viewed by many investors as a potential blockbuster.
Amgen is conducting late-stage trials of the drug in patients with and without diabetes, and said results from a Phase 2 diabetes trial will be announced in the second half of this year.
The company also said the U.S. Food and Drug Administration has lifted its clinical hold on an early-stage trial of a different experimental weight-loss drug known as AMG 513.
For the full year, Amgen said it still expects adjusted earnings per share of $20.00 to $21.20 on revenue of $34.3 billion to $35.7 billion. Analysts, on average, have estimated earnings of $20.63 per share on revenue of $35.1 billion.
Amgen said its 2025 outlook includes the impact of implemented tariffs, but does not account for any future levies, including potential sector-specific tariffs.
U.S. President Donald Trump's administration has opened a national security investigation into pharmaceuticals in a bid to demonstrate why the U.S. needs tariffs to boost domestic manufacturing.
Amgen's first-quarter sales of bone drug Prolia rose 10% to $1.1 billion, but the company said it expects lower sales of the medication later in the year as biosimilar competitors are launched.
Sales of cholesterol-lowering medication Repatha rose 27% to $656 million, while sales of much older arthritis drug Enbrel fell 10% to $567 million.
In the rare disease space, sales of thyroid eye disease drug Tepezza fell 10% to $381 million, and sales of gout treatment Krystexxa were flat at $236 million. Both drugs were acquired with Amgen's purchase of Horizon Therapeutics.
Net operating income for the quarter rose 20% to $1.2 billion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
4 minutes ago
- Reuters
Surging goods, services prices boost US producer inflation
WASHINGTON, Aug 14 (Reuters) - U.S. producer prices increased by the most in three years in July amid a surge in the costs of goods and services, suggesting a broad pickup in inflation was imminent, potentially jeopardizing an anticipated interest rate cut from the Federal Reserve next month. The stronger-than-expected producer inflation report from the Labor Department on Thursday followed on the heels of data this week showing consumers paid higher prices for services like dental care and airline fares last month. Economists had hoped that moderate services price gains would blunt the inflationary impact of higher goods prices from President Donald Trump's sweeping import tariffs. The U.S. central bank puts more emphasis on services inflation given that economy is mostly services driven. Financial markets expect the Fed to resume rate cuts in September, but much will depend on August's employment and inflation data. "This is a kick in the teeth for anyone who thought that tariffs would not impact domestic prices in the United States economy," said Carl Weinberg, chief economist at High Frequency Economics. "This report is a strong validation of the Fed's wait-and-see stance on policy changes." The producer price index for final demand jumped 0.9% last month, the largest advance since June 2022, after being unchanged in June, the Labor Department's Bureau of Labor Statistics said. Economists polled by Reuters had forecast the PPI rising 0.2%. Goods prices vaulted 0.7%, the biggest gain since January, after climbing 0.3% in June. A 1.4% surge in food prices accounted for 40% of the broad increase in the cost of goods. Food prices were driven by a 38.9% acceleration in the cost of fresh and dry vegetables. There were also increases in the prices of meat and eggs. Excluding food and energy, goods prices increased 0.4%, with strong rises in the costs of steel, aluminum and primary nonferrous metals. Services prices soared 1.1%, the largest gain since March 2022, amid strong increases in machinery and equipment wholesaling, and costs of portfolio management, hotels and motels, and road transportation of freight. In the 12 months through July, the PPI increased 3.3% after advancing 2.4% in June. "While businesses have assumed the majority of tariff costs increases so far, margins are being increasingly squeezed by higher costs for imported goods," said Ben Ayers, senior economist at Nationwide. "We expect a stronger pass-through of levies into consumer prices in coming months with inflation likely to climb modestly over the second half of 2025." U.S. stocks opened lower. The dollar rose against a basket of currencies. U.S. Treasury yields rose. With the July report, the BLS ended the calculation and publication of approximately 350 indexes, including data from the PPI Final Demand-Intermediate Demand, special index, industry and commodity classifications. The agency has suffered years of underfunding under both Republican and Democratic administrations, a situation worsened by an unprecedented campaign by President Donald Trump's White House to remake the federal government through deep spending cuts and mass layoffs of public workers. The resource constraints have impacted the closely watched employment report and also resulted in the suspension of data collection for portions of the CPI basket in some areas across the country. This has raised concerns about the quality of the government-produced economic data, long viewed as the gold standard. The nomination of Heritage Foundation economist E.J. Antoni, a critic of the BLS, to head the statistics agency, is also adding another layer of worry over data quality. The government on Tuesday reported a mild increase in consumer prices in July, though rising costs for services like dental care and airline tickets caused a measure of underlying inflation to post its largest gain in six months. The Fed left its benchmark overnight interest rate in the 4.25%-4.50% range last month for the fifth-straight time since December. Prior to the PPI report, economists estimated the Personal Consumption Expenditures (PCE) Price Index, excluding the volatile food and energy components, increased 0.3% in July after a similar gain in June. That would raise the year-on-year increase in the so-called core PCE inflation to 2.9% from 2.8% in June. Core PCE inflation is one of the measures tracked by the Fed for its 2% target. A separate report from Labor Department showed initial claims for state unemployment benefits dropped 3,000 to a seasonally adjusted 224,000 for the week ended August 9. Economists had forecast 228,000 claims for the latest week. The labor market has split into low firings and tepid hiring as businesses navigate trade policy, which has raised the nation's average import duty to its highest in a century. Employment gains averaged 35,000 jobs per month over the last three months, the government reported in early August. Domestic demand grew in the second quarter at its slowest pace since the fourth quarter of 2022. The number of people receiving benefits after an initial week of aid, a proxy for hiring, slipped 15,000 to a seasonally adjusted 1.953 million during the week ending August 2, the claims report showed. The elevated so-called continuing claims align with consumers' growing perceptions that jobs are hard to find. Economists view the continuing claims trend as consistent with the unemployment rate rising to 4.3% this month from 4.2% in July.
Reuters
4 minutes ago
- Reuters
Breakingviews - Facebook teaches early lesson in unbounded AI risk
NEW YORK, Aug 14 (Reuters Breakingviews) - Artificial intelligence calls for a rethink on the tradeoffs between technological utility and risk. Unguided chatbot responses, for example, cannot be neatly constrained. Attempts to do so will either be insufficient or entangle developers in a morass of third-rail social issues. Just look at Facebook owner Meta Platforms (META.O), opens new tab, where internal AI guidelines incredibly and explicitly allowed 'sensual' conversations with children and racist arguments. The chance of backlash is underpriced. Meta's 'Content Risk Standards' framework for its generative AI includes a range of controversial guidelines, according to a Reuters special report published on Thursday. Examples of acceptable responses include comments on an 8-year-old's body to 'statements that demean people on the basis of their protected characteristics,' like race. It follows Wall Street Journal probes, opens new tab on Meta chatbots engaging in sexually explicit conversations with users identifying as minors. A spokesperson told Reuters that the company is in the process of revising its guidelines and that such conversations with children never should have been allowed, adding that the 'examples and notes in question were and are erroneous and inconsistent with our policies.' U.S. lawmakers already have dragged Meta CEO Mark Zuckerberg into hearings over whether Facebook or its sister app Instagram pose harms to children. The difference with AI is that the company produces the dangerous content. Reuters also chronicled the story of one man's spiral into fantasy with a flirtatious chatbot. Repeated interventions to protect children, including age limits in places like Australia, have done little to slow the $2 trillion social media juggernaut. AI represents a whole new proposition, however, because its instability is inherent to the product, forming its core use case and its greatest weakness. Happyish mediums can be reached, as in coding, but putting kids in harm's way is far harder to brush off than a Python glitch. Beyond the potential psychological harms, going off-script can be disastrous for businesses. In a 2024 case, opens new tab, a tribunal found airline Air Canada responsible for misinformation given by its AI helper to a customer. Sebastian Siemiatkowski, CEO of buy-now-pay-later giant Klarna (KLAR.N), opens new tab, told Bloomberg, opens new tab that its pivot into automated customer service agents led to 'lower quality.' Citizens of Silicon Valley famously prefer to seek forgiveness rather than permission. The headlong rush into AI, while largely brushing aside guardrails, pushes the ethos to a new level. There were more than $120 billion of venture-capital-backed deals in large language models and machine learning in the first half of 2025, according to PitchBook data, opens new tab, nearly matching last year's entire tally. Valuations are also climbing unabated; OpenAI's jumped from $300 billion to $500 billion in a matter of days. Seductive rewards are glossing over AI's inherent risks. Follow Jonathan Guilford on X, opens new tab and Linkedin, opens new tab.
Reuters
4 minutes ago
- Reuters
Wall St slips as hot producer inflation data dampens rate-cut bets
Aug 14 (Reuters) - Wall Street's main indexes declined on Thursday, after a hotter-than-expected producer prices report dampened investor expectations of potential interest-rate cuts by the Federal Reserve this year. A Labor Department report showed the Producer Price Index rose 3.3% on an annual basis in July, higher than the 2.5% gain expected by economists polled by Reuters. On a monthly basis, it rose 0.9%, compared with an estimated 0.2% rise. Traders lowered their Fed rate-cut expectations for the rest of the year to about 58 basis points, according to data compiled by LSEG, compared with around 63 bps before the report. But they are still fully pricing in a quarter-percentage-point cut in September. "It's sending a mixed message about the economy," said Peter Andersen, founder of Andersen Capital Management in Boston. "We have been too anxious to draw a conclusion that the economy is fine, it's not overheated. But this wholesale data does show that perhaps there is some inflation working and we shouldn't be so quick to conclude that we need to cut interest rates." At 09:42 a.m. ET, the Dow Jones Industrial Average (.DJI), opens new tab fell 164.29 points, or 0.37%, to 44,757.98, the S&P 500 (.SPX), opens new tab lost 16.84 points, or 0.26%, to 6,449.74 and the Nasdaq Composite (.IXIC), opens new tab lost 22.69 points, or 0.10%, to 21,690.45. Recent data reflecting labor market weakness and a moderate rise in consumer prices had strengthened expectations that the central bank will potentially lower interest rates next month. However, Thursday's report fanned concerns that U.S. tariffs on imports could start to impact prices in the coming months and dampen a rally in U.S. stocks that had helped the benchmark S&P 500 (.SPX), opens new tab and tech-heavy Nasdaq (.IXIC), opens new tab log record highs over the past two sessions. On Thursday, nine of the 11 S&P 500 sectors declined, with materials (.SPLRCM), opens new tab, down 1.2%, falling the most. Rate-sensitive small-caps (.RUT), opens new tab and housing stocks (.HGX), opens new tab also dropped more than 1% each. Separate data showed the number of Americans filing new applications for jobless benefits fell last week amid low layoffs. A report also showed San Francisco Fed President Mary Daly pushed back against the need for a 50-basis-point interest rate cut next month, a day after Treasury Secretary Scott Bessent said an aggressive half-point cut was possible. Cisco Systems (CSCO.O), opens new tab lost 1% after the network equipment manufacturer's broadly in-line forecast did little to encourage investors. Deere & Co (DE.N), opens new tab fell 8% after the farm-equipment maker reported a lower quarterly profit and tightened its annual profit forecast, while Tapestry (TPR.N), opens new tab plunged 17.6% after the Coach handbag maker forecast annual profit below estimates. Both companies warned of tariffs impacting their business. Later in the day, investors will also tune into remarks from St. Louis Fed President Alberto Musalem, a Federal Open Market Committee voting member this year. Declining issues outnumbered advancers by a 5.05-to-1 ratio on the NYSE and by a 3.38-to-1 ratio on the Nasdaq. The S&P 500 posted four new 52-week highs and no new lows while the Nasdaq Composite recorded 24 new highs and 31 new lows.
